Use of Cannabinoids in Therapeutic and Wellness Devices

Abstract

The present invention relates to a device for exposing a human body to energy. The device includes a contact surface 2 that defines an exposure area, where a human body can be placed within the coverage area of ​​the energy. The device also includes at least one means for emitting energy essentially directed toward the exposure area, and at least one means for generating a vapor mixture comprising at least one cannabinoid. The device of the present invention further includes at least one means for delivering an effective amount of a vapor mixture comprising at least one cannabinoid to an area surrounding an opening to the human body's respiratory system. The present invention further relates to a method for operating such a device, and also to the use of a vapor mixture comprising at least one cannabinoid in the described device.

Description

[Technical Field]

[0001] The present invention relates to a device for exposing the human body to energy, and to a method for operating such a device, in all cases according to the preambles of the independent claims.

[0002] The invention further relates to the use of a vapor mixture comprising at least one cannabinoid in a device for exposing the human body to energy, also according to the preamble of the independent claim. [Background technology]

[0003] Cannabinoids and their synthetic analogs are pharmaceutically active secondary substances that can be obtained primarily from extracts of the cannabis plant (Cannabaceae). Most cannabinoids are variously psychotropic substances that act on the central nervous system and are associated with, among other things, analgesic effects. Today, the use of cannabinoid-containing herbal medicinal substances for the relief of neuropathic and inflammation-related pain is widely accepted medically. Numerous studies have indicated other potential applications, which are currently being intensively investigated. For example, cannabinoids are being considered for the relief of, among other symptoms: relief of spasticity complaints, improvement of intestinal motility, antiemetic effects, reduction of intraocular pressure, and numerous adjunctive effects in the treatment of psychological and psychosomatic disorders, such as anxiety disorders.

[0004] The number of cannabis-based medicines approved for these therapeutic uses continues to increase. In most countries, cannabinoids are available only by prescription, and approval for use in medical practice is granted specifically for the treatment of chronic pain conditions, such as neuropathic pain or cancer pain, in spasticity and seizures, such as those triggered by multiple sclerosis or other neurological conditions, or for treating chemotherapy-related nausea and appetite loss. In parallel with medical use, the gradual liberalization of recreational cannabis products with reduced tetrahydrocannabinol content has led to increased acceptance of cannabinoids in Western society in general.

[0005] The use of wellness devices is common practice as an adjunct to therapeutic measures that may be associated with significant adverse effects in patients. Such devices are also used to alleviate complaints caused by stressful conditions or to promote relaxation when at least one beneficial effect can be achieved by the measures. For example, massage and light therapy can relieve stress, improve circulation, and, through beneficial mind-body effects, pave the way for a restorative relaxation process.

[0006] A suitable device may be, for example, a phototherapy device or solarium that emits a dose of light and / or UV energy to counteract seasonal mood changes in a patient, for example, caused by reduced sun exposure. Tension relief and antispasmodic treatments may also be selectively assisted by massage devices, e.g., dry massage devices, that can selectively massage parts of the body with enclosed water jets.

[0007] Therefore, there is a need for such a therapeutic or wellness device that is suitable both as an adjunct in the relief of psychosomatic complaints or as an adjunct in therapeutic measures. Summary of the Invention

[0008] SUMMARY OF THE INVENTION It is therefore an object of the present invention to overcome at least one disadvantage in the prior art.

[0009] In particular, it is an object of the present invention to provide a device of the kind mentioned in the introduction, suitable for carrying out therapeutic and / or wellness treatments, for such purposes the device should preferably be safe in use and allow for precise application of treatment parameters.

[0010] Furthermore, it is an object of the present invention to provide a suitable method for the operation of the device of the present invention and to provide the use in said device of a vapor mixture comprising at least one herbal medicinal substance.

[0011] At least one of these objects is achieved by the features of the independent claims.

[0012] One aspect of the present invention relates to a device for exposing a human body to energy, the device including a contact surface defining an exposure area, the human body being capable of being positioned in the exposure area so as to be within the coverage area of ​​the energy.

[0013] The device also includes at least one means for emitting energy substantially directed toward the exposed area. Additionally, the device includes at least one means for producing a vapor mixture comprising at least one cannabinoid.

[0014] Additionally, the device of the present invention comprises at least one means for delivering a vapor mixture comprising an effective amount of at least one cannabinoid to an area surrounding an opening to the respiratory system of the human body.

[0015] For the purposes of the present invention, suitable cannabinoids may be understood to mean not only those which can be extracted naturally from the referred plant family of the cannabis plant, in particular from cannabis or hemp, but also analogues obtained by isomerisation of suitable precursors, for example from cannabidiol to tetrahydrocannabinol, and those which are produced synthetically. The best known cannabinoids are those which can be obtained from the cannabis plant by extraction, Δ 9 -tetrahydrocannabinol. Methods of extraction are known to those skilled in the art.

[0016] For the purposes of the present invention, the area surrounding an opening to the respiratory system of the human body may be, for example, the head region of the human body, the area surrounding at least the nose and mouth.

[0017] For the purposes of the present invention, the contact surface can be a lying surface that is essentially horizontal in design. Contact surfaces including a seat or backrest on which the relevant human body can sit and / or lean can also be possible. In one particular embodiment, the contact surface is a floorboard or standing surface on which a person can stand within the exposure area so that the person is within the energy coverage area.

[0018] For the purposes of the present invention, an effective amount can be understood to mean a dose of an active substance, particularly a cannabinoid, in a vapor mixture that achieves the desired pharmacological effect in a statistically relevant proportion of people. The desired pharmacological effect can be determined by those skilled in the art according to the therapeutic outcome to be achieved. For example, in a device of the present invention used for recreational purposes, such as in wellness treatments, the effective amount is set appropriately low, so that, for example, muscle relaxation or a pleasant feeling of well-being is achieved. For medical / therapeutic use, the effective amount can be selected with respect to the therapeutic intent to be achieved. For example, the effective amounts for different cannabinoids may vary depending on the pharmacological effect. Corresponding effective amounts are indicated in legal guidelines and guidelines prescribed by pharmacopoeias (see, in particular, the Swiss Pharmacopoeia or the European Pharmacopoeia). For the most well-studied cannabinoids, such as THC, effective amounts within the range of 5 mg to 60 mg per day, administered daily in tablet form, are specified. In the case of a medicine administered in liquid form, for example for the treatment of glaucoma, a THC concentration of, for example, 1-7% is envisaged for a single dose of daily treatment.

[0019] In one particular embodiment, the effective amount can be adjusted based on an oil-based vaporizer having a THC content of 0.1% to 1% by volume and a cannabidiol content of 10% to 20% by volume.

[0020] In one particular embodiment, the effective amount can be adjusted depending on the amount of cannabinoid in the vaporizer, particularly when the effective amount is between 36% and 61% of the cannabinoid content of the vaporizer in the vapor mixture. For example, during operation, the proportion of cannabinoid from the vaporizer that is available in the vapor mixture as an effective amount could be adjusted by one skilled in the art based on the temperature and the manner in which the vapor mixture is generated, for example by conduction, convection, and / or sonication.

[0021] In a specific embodiment of the present invention, the area surrounding the opening to the respiratory system of the human body is a defined area. This defined area can, for example, include a specific volume. Therefore, based on this defined volume, the user can adjust the appropriate effective dose for the desired effect. For example, the vapor mixture can establish a defined atmosphere that ensures that the appropriate effective dose can be achieved by inhaling the vapor mixture within the area surrounding the opening to the respiratory system. This can increase the safety of the device of the present invention, and in particular, can prevent unwanted side effects, such as psychotropic effects.

[0022] The present invention provides a device as mentioned in the introduction, which is therapeutically safe and synergistically combines the beneficial effects of energy exposure with treatment with herbal medicinal substances, and which is able to optimally promote therapeutic and / or wellness effects, in particular with a vapor mixture containing an effective amount of cannabinoids. Safe administration of an appropriate effective amount is possible, preventing, for example, overdosing resulting in unwanted psychotropic side effects, or underdosing not achieving the desired therapeutic effect, in particular by establishing a defined area surrounding the opening to the respiratory system.

[0023] In one particular embodiment, the means for emitting energy directed essentially at the exposed area is designed to emit electromagnetic energy.

[0024] Particularly preferably, the electromagnetic energy is radiant energy. Very particularly preferably, the radiant energy is UV radiation.

[0025] In one particularly preferred embodiment, the means for emitting energy essentially directed at the exposure area is a light source. The light source may be tailored to reflect a particular color spectrum. This may be achieved by equipping the light source with an appropriate filter.

[0026] Particularly preferably, the light source is capable of emitting light in the visible spectrum, which may include the range from about 400 nm to about 1100 nm, in particular the range from about 400 nm to about 750 nm.

[0027] In a particularly preferred embodiment, the light source comprises a filter that absorbs and / or reflects harmful UV radiation, which in the region below 380 nm can be particularly harmful to health.

[0028] Particularly preferably, the light source is designed to reflect and / or absorb UV radiation in the range of 200 to 380 nm.

[0029] In a particularly preferred embodiment, the light source is a solarium lamp. Solariums are widely used as wellness devices, intended to achieve, for example, tanning of the skin for cosmetic reasons or to achieve beneficial wellness effects by exposure to UV light. In medicine, solariums are used to treat certain skin diseases.

[0030] In one particular embodiment, the contact surface is the lying surface of a solarium unit for exposure to UV light while lying down.

[0031] In a further particular embodiment, the contact surface is a standing area of ​​a standing solarium for exposure to UV light while standing.

[0032] In one particularly preferred embodiment, the light source is an LED-based UV radiation source.

[0033] Solariums have been shown to treat seasonal mood changes, particularly those caused by insufficient light exposure, and to reduce or completely eliminate them. This treatment can be further improved by the device of the present invention and by producing effective amounts of cannabinoids in the area surrounding the opening to the respiratory system during treatment. This can, for example, shorten the overall treatment time, which can overall help reduce the amount of radiation to the body.

[0034] In one particular embodiment, the means for emitting energy essentially directed at the exposed area is designed to emit kinetic energy. Particularly preferably, the means is designed to emit a directed jet of fluid.

[0035] In one particular embodiment, the means for emitting energy essentially directed at the exposed area is a jet nozzle designed to emit a jet of fluid, in particular a jet of water, at the exposed area. Such a jet nozzle is particularly capable of releasing muscle tension in a targeted and therefore gentle manner for the user. This is done, for example, by directing a targeted water jet of a defined intensity at the body part via the nozzle. Devices that allow treatment with a water jet in a dry state are also known.

[0036] Device for dry massage with a jet of water (DE 202019105636 A1) comprises one such dry massage device, in which a waterproof cover is designed so that the body in the energy coverage area is not wetted by the jet of water, in other words, the water is hermetically held by an impermeable membrane.

[0037] In one particular embodiment of the invention, the means for generating the vapor mixture is a vaporizer.

[0038] For the purposes of the present invention, a vaporizer can be understood to mean a device for vaporizing an active substance. Such a device allows for gentle heating of the active substance, i.e., only to the extent necessary for the active substance to vaporize. Thus, oxidation of the active substance can be prevented. Vaporizers for ingesting recreational substances, such as tobacco, cannabis, or other herbs, are known. Vaporizers are also known from medicine, for example, in the field of anesthesia, for generating a predetermined effective amount of an active substance for anesthesia and delivering this effective amount to an area surrounding an opening to the human respiratory system. The vapor mixture can be generated using a composition containing a predetermined amount of the active substance. It is possible to set the appropriate effective amount by adjusting the operating parameters for vaporization and feedback, for example, for a defined area surrounding an opening to the human respiratory system. In addition to the active substance, the composition may contain an excipient, such as propylene glycol or glycerol.In addition to cannabinoids, compositions that may be used according to the invention may also contain other herbal medicinal substances suitable for vaporization, in particular lion's tail (Leonotis leonurus), ayahuasca (Banisteriopsis caapi), valerian (Valeriana officinalis), blue lotus (Nymphaea caerulea), damiana (Turnera diffusa), eucalyptus (Eucalyptus globulus), fly agaric (Amanita muscaria), hops (Humulus lupulus), Iceland moss (Cetraria islandica), St. John's wort (Hypericum perforatum), chamomile (Chamomilla recutita), kratom (Mitragyna speciosa), lavender (Lavandula spp.), purple passionflower (Passiflora incarnata), peppermint (Mentha × piperita), sage (Salvia officinalis, yarrow (Achillea spp.), chinquapin (Heimia salicifolia), wild rue (Peganum harmala), thyme (Thymus vulgaris), sage of the divinorum (Salvia divinorum), yohimbe (Pausinystalia yohimbe), and lemon balm (Melissa officinalis).

[0039] Particularly preferably, the composition comprises cannabinoid Δ 9 -Tetrahydrocannabinol (C 21 H 30 O2). Suitable compositions can be obtained, for example, using pharmaceutically available dronabinol containing THC in an amount of 1% to 2% by volume.

[0040] In one particular embodiment of the invention, the means for delivering a vapor mixture comprising an effective amount of at least one cannabinoid to an area surrounding an opening to the respiratory system of the human body comprises a holding means, particularly preferably a holding hood.

[0041] The holding hood is preferably suitable for producing and maintaining an effective amount of at least one cannabinoid in a vapor mixture in an area surrounding an opening to the human body's respiratory system. Particularly preferably, the holding hood is designed with a defined volume. Very particularly preferably, the holding hood is positioned within the energy coverage area so that the opening to the human body's respiratory system is completely contained within the holding hood. In a preferred embodiment, the holding hood is not completely closed, so that gas exchange with the outside environment can occur. The holding hood is preferably designed so that an atmosphere containing the vapor mixture can be formed around the opening to the human body's respiratory system, but exhaling the body through the nose sends the exhaled air outside the holding hood. Particularly preferably, the holding hood is closed in the crown region of the person's head and open in the chin region, so that exhaling sends the exhaled air outside the holding hood.

[0042] In one particular embodiment, the holding hood is coated on the inside. A possible coating would be a nano-texture, for example, to create a lotus effect that prevents fogging of the holding hood.

[0043] A retention hood of such design advantageously does not adversely affect the radiant energy that passes through the retention hood and is then exposed to the body. Such a retention hood may find use, for example, in a solarium where the tanning effect on the user's head is not limited by the solarium.

[0044] Even more surprisingly, cannabinoids and especially THC ((-)-Δ 9 Regardless of the chemical structure of the cannabinoid (trans-trans-tetrahydrocannabinol), it has been found that potential exposure to UV radiation does not result in any degradation of the cannabinoid in the vapor mixture during the exposure period.

[0045] A suitable exposure period may be from 1 minute to 30 minutes, in particular from 5 to 15 minutes, very particularly preferably about 8 minutes.

[0046] In a particular embodiment, the holding hood is designed to be essentially transparent to electromagnetic waves. Particularly preferably, the holding hood is transparent to electromagnetic waves in the wavelength range of 380 nm to 1100 nm, more particularly 380 nm to 750 nm. For this purpose, the holding hood can be made, for example, from UV-transparent polymethylmethacrylate (plexiglas). Particularly preferably, at least the area lying within the exposure area between the human body and the means for emitting energy essentially directed toward the exposure area is made from a material that is essentially transparent to electromagnetic waves.

[0047] In a particular embodiment, the holding hood is an integral part of the device for exposing the human body to energy. For example, the holding hood can be part of the lid element in the case of a solarium. The lid element can be a movable part of the solarium that defines, together with at least one contact surface, the area surrounding the opening to the human body's respiratory system and the exposure area. In the case of a standing solarium, two lid elements can be provided.

[0048] In one particular embodiment, the device for exposing the human body to energy is a solarium having a lying surface as a contact surface, and the holding hood is 450 dm 3 ~1000dm 3 , preferably 580dm 3 ~800dm 3 The closure element is an integral part of the lid element so as to define a volume of the closure element, which volume is preferably the area surrounding the opening to the respiratory system of the human body.

[0049] In one particular embodiment, the device for exposing the human body to energy is a solarium having a standing area as a contact surface, and the holding hood is 1000 dm 3 ~2000dm 3 , preferably about 1100 dm3 The at least two lid elements are integral parts of the at least two lid elements so as to define a volume, which is preferably the area surrounding the opening to the respiratory system of the human body.

[0050] Many solarium units are designed to be closable so that it is possible to enter a covered area for exposure to light, the covered area being defined by one or more lid elements with at least one contact surface. This type of solarium unit can be designed to be closable so that the entire internal volume can consequently be considered as the area surrounding the opening to the human respiratory system and can be filled with an appropriate vapor mixture.

[0051] In one particular embodiment, the holding hood is 200 dm 3 ~400dm 3 , preferably 250dm 3 ~350dm 3 , more preferably about 275 dm 3 This volume is preferably the area surrounding the opening to the respiratory system of the human body.

[0052] The retention hood may, in a further embodiment, be equipped with a pivot bearing so that the retention hood can be converted from an open state to a closed state.

[0053] In one particular embodiment, the holding hood is designed to essentially prevent the escape of the vapor mixture from the area surrounding the opening to the respiratory system of the human body. For this purpose, the holding hood may be provided with a suction opening or a blower that can prevent the escape of vapors or suck in the escaping vapor mixture, respectively. Holding hoods that are essentially conical in design are also possible, in which the vapor mixture collects at the tip of the cone as a result of its relatively higher temperature compared to the ambient air. At the end of the treatment, the holding hood can, for example, be suctioned.

[0054] In one particular embodiment, the device of the present invention comprises a storage tank for a vaporizer comprising at least one cannabinoid.

[0055] In a further particular embodiment, the device comprises a heating element for heating a predetermined amount of vaporizer so as to form a vapor mixture comprising a predetermined amount of at least one cannabinoid.

[0056] In one particular embodiment, the heating element may be designed so that it acts directly on the vaporizer. Alternatively and / or additionally, the heating element may be designed so that it acts indirectly on the vaporizer.

[0057] In one particular embodiment, the heating element is designed to heat the vaporizer by conduction.

[0058] In an additional and / or alternative embodiment, the heating element is designed to heat the vaporizer by convection.

[0059] In an alternative and / or additional embodiment, the generation of a vapor mixture containing a defined amount of at least one cannabinoid is carried out without heating. This can be achieved, for example, by mixing an air stream with a saturated atmosphere containing the appropriate cannabinoid. Alternatively and / or additionally, an ultrasonic nebulizer may be provided to generate the vapor mixture.

[0060] In a particular embodiment, the vaporizer containing at least one cannabinoid is a solid or liquid-based composition suitable for inhalation administration containing at least one cannabinoid.Suitable solid or liquid-based vaporizers are known.Vaporization of cannabinoids can be carried out directly from the liquid phase or directly from the base by sublimation.

[0061] In one particular embodiment, the heating element is designed to achieve a temperature range of 100° C. to 235° C. for the production of the vapor mixture. Particularly preferably, the heating element is designed for a temperature range of 165° C. to 200° C., very particularly preferably about 200° C.

[0062] In one particular embodiment, the vaporizer comprises additional excipients in addition to the active substance / herbal medicinal substance / cannabinoid.

[0063] In one particular embodiment, these excipients are selected from the group consisting of propylene glycol, glycerol, water, dexpanthenol, other aromatic and / or non-aromatic oils, fragrances, or substances that modify the viscosity of the vaporizer.

[0064] In one particular embodiment, the device comprises at least one fan for generating an airflow in the area surrounding the opening to the respiratory system of the human body. Particularly preferably, the airflow is designed to remove a vapor mixture containing an effective amount of at least one cannabinoid from the holding hood. In this embodiment, the fan can be useful for supplying fresh air to the area surrounding the opening to the respiratory system, particularly within the holding hood.

[0065] Alternatively and / or additionally, the fan may be designed to remove the vapor mixture containing at least one cannabinoid from the holding hood and the area surrounding the opening to the respiratory system at the end of the treatment and / or wellness session. Such removal can ensure that the treatment time is not exceeded and that an effective amount is administered only for a specific, defined period. This period can particularly preferably be synchronized with the exposure to energy. Thus, the treatment and / or wellness session can be adjusted accordingly to best benefit from the synergistic effect of the exposure to energy and the desired therapeutic use of cannabinoids, such as dry massage with a water jet or irradiation with UV radiation.

[0066] In a particular embodiment, the device of the present invention includes at least one photoelectric sensor. Particularly preferably, this photoelectric sensor is designed to determine at least one photoelectrically measurable physiological parameter of the human body in the energy coverage area. For example, the photoelectric sensor may be a sensor for measuring light pulses. Alternatively and / or additionally, the photoelectric sensor may also be a UV sensor, for example, measuring the amount of absorbed UV radiation or the intensity of this UV radiation.

[0067] In a particular embodiment, the sensor can be designed to control the operating parameters of the device, allowing for control and adjustment of individual device parameters, for example, over the course of a treatment. For example, in a dry massage device equipped with a holding hood and a device for generating a vapor mixture containing an effective amount of cannabinoids, the desired therapeutic effect can be adjusted, for example, based on the blood flow of a specific target in the surface tissue. The appropriate effective amount is variably set so that it is appropriately matched to the exposure to kinetic energy through the massage bed to achieve an appropriate target value, which is measured by a photoelectric sensor and adjusted via a control unit through direct control of the massage nozzle and / or the means for generating the vapor mixture in the area surrounding the opening to the human respiratory system.

[0068] In one particular embodiment, the device of the present invention comprises a control unit that adjusts and / or controls the operating parameters of the means for generating the vapor mixture and the means for emitting energy essentially directed towards the exposure area. This control unit may further be designed to receive measurement data from sensors, such as the photoelectric sensors described above, and to evaluate and convert these data into appropriate control signals, by which the desired effect will be achieved.

[0069] In a particular embodiment, the device of the invention is a bioelectronic sensor. Particularly preferably, the bioelectronic sensor is a sensor suitable for measuring resistance. Sensors of this type are already used to measure resistance in the body, for example, to measure respiratory rate and / or body fat percentage.

[0070] In one particular embodiment, the means for delivering a vapor mixture comprising an effective amount of at least one cannabinoid to an area surrounding an opening to the respiratory system of a human body comprises an inlet opening that delivers a vapor mixture generated outside the holding hood to the interior of the holding hood.

[0071] In one particular embodiment, the holding hood is essentially cup-shaped in design, such that the holding hood is suitable for at least partially surrounding at least a portion of the head and / or upper body of a human body undergoing treatment with the device of the present invention. Particularly preferably, the holding hood is designed as a container suitable for maintaining a suitable atmosphere containing an effective amount of at least one cannabinoid for a particular period of time.

[0072] In one particular embodiment, the means for delivering a vapor mixture containing an effective amount of at least one cannabinoid to the area surrounding the opening to the respiratory system of the human body comprises at least one outlet opening. Particularly preferably, the outlet opening is connected to an inhalation device. The outlet opening may be designed to evacuate a suitable atmosphere. This may include the outlet opening also being operably connected to a fan as further described above, for example, by the presence of a hose connection between the outlet opening and the fan.

[0073] A further aspect of the present invention relates to a method for operating the described device. The method comprises the step of providing a device for exposing a human body to energy. Particularly preferably, the device has any non-mutually exclusive combination of the features of the device of the present invention described above. Additionally, a vaporizer is provided comprising at least one vaporizable herbal medicinal substance. Particularly preferably, the herbal medicinal substance is a cannabinoid. The method further comprises the step of vaporizing the vaporizer to result in the formation of a vapor mixture comprising an effective amount of the at least one herbal medicinal substance. Particularly preferably, a vapor mixture comprising an effective amount of the at least one cannabinoid is formed.

[0074] The vapor mixture is delivered to an area surrounding an opening to the human body's respiratory system. This can be achieved, for example, by providing a suitable hose connection and / or inlet opening that delivers the generated vapor mixture to a portion of the exposure area, where the opening to the human body's respiratory system is located within the exposure area. Particularly preferably, the vapor mixture is delivered to an area surrounding the opening to the human body's respiratory system so that an effective amount of at least one cannabinoid is formed inside the holding means. Particularly preferably, the holding means is a holding hood.

[0075] The method of the present invention may further include the step of regulating, controlling and / or adjusting the vaporization of the vaporizing agent in an exposure routine generated by the device.

[0076] The method of the present invention may also provide for the measurement or detection of a specific parameter. For example, a given physiological state may be used to adjust the effective amount. In a specific embodiment, the effective amount may be defined within a specific range representing a tolerance, where a given physiological value is achieved within the tolerance. For example, a vapor mixture may provide an effective amount of cannabinoids, the effective amount comprising 5 mg to 15 mg of THC. The exact amount of the effective amount depends on a given physiological parameter measured by a sensor and signaled to a control unit. If the physiological parameter is achieved, the effective amount is not increased. In this specific example, the device may be designed to increase the effective amount in stages. In this specific example, this may mean that the agent provided for convective heating of the vaporizer bypasses the airflow to the vaporizer for as long as necessary to reach the desired effective amount / until the sensor signals the physiological parameter to the control unit. To prevent further increases in the effective amount, for example, a bypass can be provided in which the airflow is no longer directed past the vaporizer, and therefore no further THC reaches the area surrounding the airways, i.e., the retention hood in certain instances.

[0077] A further aspect of the invention relates to the use of a vapor mixture comprising at least one cannabinoid in a device for exposing a human body to energy, which is achieved by delivering an effective amount of a vapor mixture comprising at least one cannabinoid to an area surrounding an opening to the respiratory system of the human body.

[0078] It has been found that there is a synergistic effect between the use of a device for exposing the human body to energy and a vapor mixture containing at least one cannabinoid.In wellness treatment, particularly, low doses of cannabinoid concentrations in the area surrounding the opening to the human respiratory system can achieve enhanced relaxation effects and enhance the overall well-being of the person.

[0079] The present invention is also suitable for the medical treatment sector, where the range of treatments can range from treatment methods for the reduction of side effects and pain to the improvement of psychosomatic complaints.

[0080] In one particular embodiment, the use according to the present invention comprises exposing a person to light and using an effective amount of at least one cannabinoid in the form of a vapor mixture to reduce psychosomatic complaints and increase overall well-being.

[0081] In a further embodiment, the use according to the invention comprises the use of a vapor mixture comprising at least one cannabinoid in combination with exposing the patient to kinetic energy, for example by jets of water from a massage nozzle, preferably a dry massage device of the type described in the introduction, to reduce psychosomatic complaints and increase overall well-being.

[0082] In a particular embodiment, psychosomatic complaints include seasonal mood states, such as those that may occur in winter.It has been shown that seasonal mood changes in winter can be attributed to insufficient sunlight.Surprisingly, it has been found that the combined treatment of cannabinoids and appropriate exposure to, for example, ultraviolet light, can effectively alleviate the psychosomatic complaints associated with seasonal mood changes, even after only a short treatment session.

[0083] In one particular embodiment, the use according to the invention comprises a holding hood suitable for producing and maintaining an effective amount of at least one cannabinoid in an area surrounding an opening to the respiratory system of the human body.

[0084] For purposes of the present invention, the use of at least one cannabinoid also includes synthetic analogs, such as dimethylheptylpyran (DMHP).

[0085] In a particular embodiment, the use involves a vaporizer having a specific concentration of cannabinoids. This vaporizer may also be produced using herbal extracts from cannabis plants. Alternatively and / or additionally, the direct use of parts of cannabis plants is also suitable for producing vaporizers with appropriate active substance contents. Particularly suitable for this purpose are pharmacognostically determined and standardized herbal medicinal substances containing parts of cannabis plants. For example, finely ground powder from cannabis plant flowers (cannabis floss) is particularly suitable.

[0086] Almost all exogenous cannabinoids are basically suitable for use according to the present invention. Up to 70 types of cannabinoids are known in total. The effective amount can be adapted to the desired effect. For example, at low doses, analgesic effects and sometimes sedative-hypnotic effects can be achieved. After overdose or at very high doses, a state of altered consciousness may occur. Those skilled in the art will be familiar with the effective amount for treating increased intraocular pressure, pain, hypertension, nausea, anorexia, or even as an appetite suppressant.

[0087] In a particular embodiment, the use according to the present invention can comprise the use of electromagnetic energy, particularly radiation energy.In this use, an effective amount of at least one cannabinoid is administered in combination with radiation therapy, particularly preferably UV radiation therapy.This combination has been found to be particularly advantageous in the treatment of seasonal mood swings.

[0088] In a further particular embodiment, the use according to the invention involves the use of kinetic energy. Particularly preferably, kinetic energy is used in the form of a directed fluid jet. This can be achieved, for example, by a jet of water directed from a nozzle in a targeted manner towards the part of the body of the individual receiving treatment. Water massage devices of this type are known. Particularly preferably, the water massage device used is one that does not wet the body, i.e., is suitable for dry massage. Such devices have a membrane that holds the water jet, but the deformation of the membrane allows the kinetic energy to be transferred to a certain extent to the human body.

[0089] Surprisingly, it has been found that the use of such a massage device in conjunction with the administration of an effective amount of cannabinoids is particularly suitable for the relief of muscle tension, stress states and circulation-related stiffness of muscle tissue.

[0090] It goes without saying that the implementation by the present invention of the described devices, corresponding methods and corresponding uses can be achieved by any combination of the described features, provided that they are not mutually exclusive. Further advantageous features will be discernible to those skilled in the art from the detailed description and specific embodiments below.

[0091] The invention is explained in more detail below with reference to particular figures and exemplary embodiments, without being limited thereto.

[0092] Exemplary embodiments of the present invention will now be described with reference to the following figures. [Brief explanation of the drawings]

[0093] [Figure 1] FIG. 1 shows a device of the present invention. [Figure 2] FIG. 2 shows the device of the present invention of FIG. 1 in use. [Figure 3] FIG. 10 shows a further embodiment of the device of the present invention. [Figure 4]FIG. 10 shows a further embodiment of the device of the present invention. [Figure 5] FIG. 10 shows a further embodiment of the device of the present invention. DETAILED DESCRIPTION OF THE INVENTION

[0094] Figure 1 shows a particularly simple embodiment of the device according to the invention: At the cranial end of the contact surface 2, which in this example is designed as a lying surface, a holding hood 1 is arranged.

[0095] In this case, the retention hood 1 may be made of, for example, a plastic material and be opaque in design. For this use, it may be advantageous if the retention hood 1 also causes a slight darkening of the head area. The retention hood 1 is closed in the crown region and opens downwards towards the lower body. The selected dimensions of this embodiment are such that the head and shoulders of a person lying on the contact surface 2 are inside the retention hood 1, while the limbs and upper body lie outside the retention hood.

[0096] The contact surface 2 may take the form of a membrane in this example. The membrane may seal a liquid-filled space in which a jet nozzle suitable for directing a jet of water at the contact surface is located, such that the membrane simultaneously defines an exposure area. In operation, a user lies on the contact surface and is exposed to kinetic energy by the water jet through the membrane. During this time, the user's head lies under the retention hood 1. The retention hood 1 may be provided with LED lighting, for example (not shown in this example), to aid relaxation. For example, a strip of red LEDs inside or around the edge of the retention hood can create a subdued, warm atmosphere that encourages relaxation.

[0097] The holding hood may be provided with inlet openings (also not shown). Through these inlet openings, a vapor mixture containing an effective amount of at least one cannabinoid can be delivered. When a patient lies with their head under the holding hood, a controlled atmosphere appears around the head, allowing a prescribed effective amount of cannabinoid to be administered to the patient. In this example, the holding hood is convex in design so that it defines a volume, within which the vapor mixture can reside.

[0098] The device of the present invention allows the wellness unit to be used for the treatment of psychosomatic complaints, such as seasonal mood changes or muscle tension, as shown in Figure 1. Depending on the intended use, a person skilled in the art can define the composition of the vapor mixture and specify the corresponding effective amount required to achieve the desired therapeutic or soothing effect.

[0099] This is explained in more detail in the example of Figure 2, which provides a schematic diagram of the device of the present invention shown in Figure 1 in use.

[0100] A contact surface 2 is also provided, on which the patient 10 can lie. A holding hood 1 can be placed on the head of the patient 10, defining an area A as a volume surrounding an opening to the respiratory system. The holding hood 1 is provided with light-emitting diodes on its inside 1.1, which are intended to enhance the relaxation effect. The holding hood 1 can also have a coating intended to prevent condensation of water vapor inside the holding hood. Condensed water vapor can lead to the formation of droplets, which is undesirable for the relaxation effect in this example. The holding hood 1 can also be provided with cooling and / or heating elements to create a suitable atmosphere or prevent the formation of condensation. The holding hood 1 is in the distal region, i.e., it can be ventilated towards the extremities through openings 1.2.

[0101] Gas exchange with the ambient environment results in a decrease in effective volume over time if the vapor mixture is not replenished. The vapor mixture is supplied into the holding hood 1 via supply connector 20. The vapor mixture, in this example, is generated by a convective vaporization process. This is achieved by circulating a stream of warm air at a predetermined temperature around the vaporizer 22 so that the desired amount of vaporizer 22 is vaporized and delivered into the holding hood 1 via supply connector 20 and outlet opening 21.

[0102] The holding hood is in this case opaque in design, but the holding hood may of course also be transparent in design in this use.

[0103] During operation, a heating element (not shown) circulates air heated to an operating temperature of 130°C to 226°C around a specified amount of vaporizer, e.g., a mixture containing 1.7 mg of finely ground cannabis, to form a vapor mixture. A temperature of approximately 185°C is particularly suitable. The cannabis used in this example has a content of at least tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN). The THC content in the standardized mixture is 3.5 to 4.5%, preferably 4.15%. CBD and CBN are present in trace amounts. The water content in this example is about 10% to 15% by weight (see also Gieringer, D. et al., "Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds," Journal of Cannabis Therapeutics, October 2008).

[0104] The resulting cannabis vapor can have a THC content of 36-61%. Based on these data, one skilled in the art can generate an effective amount of vapor mixture in a targeted manner based on the volume within the area surrounding the opening to the patient's respiratory system.

[0105] Figure 3 shows a schematic diagram of a device of the present invention having a contact surface 2 and a suitably designed holding hood 1, and shows how a suitable vapor mixture containing an effective amount of cannabinoids can be supplied into said contact surface 2 and holding hood 1 by two supply connectors 20 connected by hose connections 31 to a vaporizer 30.

[0106] A suitable embodiment of the irradiation device is shown in FIG. 4. The design shown in FIG. 4 also includes a contact surface on which the patient can lie. Unlike in the previous embodiment, the contact surface exists solely for the specific purpose of orienting the patient for energy exposure. The contact surface 2 and the opposing cover surface 5 are appropriately provided with light sources 42, 41 that define an exposure area, where the patient is exposed to light. Accordingly, in a solarium, these light sources 42, 41 are UV lamps. A holding hood 1 extends within this exposure area, defining an area A surrounding an opening to the patient's respiratory system. This holding hood 1 is connected to a vaporizer by a hose connection 31. The vaporizer uses a suitable method, such as conductive heating of the vaporizer, to generate a suitable vapor mixture that is transported into the holding hood 1 through the hose connection 31. In this example, the holding hood is naturally transparent in design and is made of UV-transparent polymethyl methacrylate, such as that used in greenhouses under the trade name Alltop®, a plexiglas. SUNACTIV GS 2458 plexiglas is likewise particularly suitable.

[0107] An alternative embodiment is shown in Figure 5, where the device is intended for seated use.

[0108] In this device too, the energy is kinetic energy and the exposure is provided by a massaging element.

[0109] Accordingly, the contact surface 2 is provided with a suitable mechanical massage device 51, such as a rotating massage stick, which can also be integrated into the membrane to increase comfort during treatment. The device stands on a base 18. During operation, the patient sits on the massage stick 51 and the holding hood 1 is closed over the patient's head so as to form a defined area A surrounding the opening to the respiratory system, said holding hood 1 being foldable in this case. The vapor mixture in the vaporizer 30 is supplied to the patient by a supply connector 20 and a nebulizer 21 via a hose connection 31 to this surrounding area A.

Claims

1. 1. A device for exposing a human body to energy, comprising: a. a contact surface (2) defining an exposure area, in which a human body can be placed within the coverage area of ​​the energy; b. at least one means for emitting said energy substantially directed at said exposed area; At least one means for producing a vapor mixture comprising at least one cannabinoid; at least one means for delivering said vapor mixture containing an effective amount of at least one cannabinoid to an area (A) surrounding an opening to the respiratory system of the human body; A device for exposing a human body to energy, comprising:

2. 2. The device according to claim 1, wherein said means for emitting said energy essentially directed towards said exposed area is designed to emit electromagnetic energy, in particular radiant energy.

3. 2. The device according to claim 1, wherein said means for emitting said energy essentially directed towards said exposed area is designed to emit kinetic energy, in particular a directed jet of fluid.

4. The device according to any one of claims 1 to 3, wherein the means for generating a vapor mixture is a vaporizer.

5. 5. A device as claimed in any one of claims 1 to 4, wherein the means for delivering a vapor mixture comprising an effective amount of at least one cannabinoid to an area (A) surrounding an opening to the respiratory system of the human body comprises a holding hood (1) suitable for producing and maintaining an effective amount of the at least one cannabinoid in the vapor mixture in the area (A) surrounding an opening to the respiratory system of the human body.

6. 6. The device according to claim 5, wherein the retaining hood is designed to be transparent to electromagnetic radiation, in particular to electromagnetic radiation in the wavelength range from 380 nm to 1100 nm.

7. 7. A device according to any one of claims 1 to 6, comprising a storage tank for a vaporiser comprising at least one cannabinoid, and a heating element for heating a predetermined amount of the vaporiser so as to produce a vapor mixture comprising a predetermined amount of said at least one cannabinoid form.

8. 8. A device according to any one of claims 1 to 7, comprising at least one fan for generating an air flow in an area (A) surrounding an opening to the respiratory system of the human body, in particular an air flow for removing the vapor mixture comprising an effective amount of at least one cannabinoid from the holding hood (1).

9. A device according to any one of claims 1 to 8, comprising at least one photoelectric sensor, in particular for determining at least one photoelectrically measurable physiological parameter of the human body in the coverage area of ​​said energy.

10. A device according to any one of claims 1 to 9, comprising at least one bioelectronic sensor, in particular for measuring resistance.

11. 11. The device of any one of claims 1 to 10, wherein the means for delivering a vapor mixture comprising an effective amount of at least one cannabinoid to an area (A) surrounding an opening to the respiratory system of the human body comprises an inlet opening for feeding a vapor mixture generated outside a holding hood into the hood.

12. 12. A device according to any one of the preceding claims, wherein the means for delivering a vapor mixture comprising an effective amount of at least one cannabinoid to an area (A) surrounding an opening to the respiratory system of the body comprises an outlet opening, in particular an outlet opening connected to an inhalation device.

13. A method for operating a device according to any one of claims 1 to 12, comprising: a. Providing a device for exposing a human body to energy according to any one of claims 1 to 12; b. Providing a vaporizer comprising at least one vaporizable herbal medicinal substance, in particular at least one cannabinoid; c) vaporizing the vaporizing agent to result in the formation of a vapor mixture comprising an effective amount of the at least one herbal medicinal substance, in particular a vapor mixture comprising an effective amount of at least one cannabinoid; d. directing said vapor mixture into an area (A) surrounding an opening to the respiratory system of said human body, in particular so that said effective amount of at least one cannabinoid is formed inside a holding means; A method comprising:

14. 14. The method of claim 13, wherein the device includes a control device, and operating parameters of the means for generating the vapor mixture and of the means for emitting the energy essentially directed toward the exposure area are regulated and / or controlled.

15. The device includes at least one sensor, and the method comprises: a) receiving, by the controller, measurement data determined by the sensor; b. evaluating the measurement data with respect to one or more operating parameters; c) converting said assessment into one or more control signals for adjusting said one or more operating parameters; 15. The method of claim 14, further comprising:

16. 1. Use of a vapor mixture comprising at least one cannabinoid in a device for exposing a human body to energy, wherein an effective amount of the vapor mixture comprising at least one cannabinoid is delivered to an area (A) surrounding an opening to the respiratory system of the human body.

17. 17. Use of a vapor mixture comprising at least one cannabinoid as described in claim 16, wherein a holding hood is provided in the area (A) surrounding the opening to the respiratory system of the human body, suitable for producing and maintaining an effective amount of at least one cannabinoid in the vapor mixture.

18. 18. Use of a vapor mixture comprising at least one cannabinoid according to claim 16 or 17, wherein the energy comprises electromagnetic energy, in particular radiant energy.

19. 18. Use of a vapor mixture comprising at least one cannabinoid according to claim 16 or 17, wherein the energy comprises kinetic energy, in particular a directed jet of fluid.

Images